Dow Jones

38,807.33

0.00%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Onyx Pharmaceuticals, Inc. (MM) (ONXX)
Onyx Pharmaceuticals, Inc. (MM) (ONXX) Noticias

ONXX

Onyx Pharmaceuticals, Inc. (MM) (ONXX)

Onyx Pharmaceuticals, Inc. (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ONXX

1 2 3 4 5 6 7 8 9 10 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
11/10/2013	15:46	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
02/10/2013	05:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
01/10/2013	15:43	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
01/10/2013	15:19	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
01/10/2013	15:14	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
01/10/2013	15:05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
01/10/2013	07:58	Edgar (US Regulatory)	(25-NSE)	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
01/10/2013	05:34	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
01/10/2013	05:21	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
01/10/2013	05:00	PR Newswire (US)	Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
18/09/2013	16:30	PR Newswire (US)	Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Onyx	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
17/09/2013	07:30	Marketwired	Onyx Pharmaceuticals Announces Data Presentations at 2013 European Cancer Congress	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
10/09/2013	08:47	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
09/09/2013	07:08	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
05/09/2013	18:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
03/09/2013	05:34	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
03/09/2013	05:08	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
30/08/2013	01:30	PR Newswire (US)	Bayer's Stivarga® (regorafenib) Tablets Approved in Europe	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
29/08/2013	14:44	PR Newswire (US)	ONYX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiducia...	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
28/08/2013	18:00	Business Wire	Faruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Onyx Pharmaceuticals, Inc. Over the Proposed Sa...	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
28/08/2013	03:30	Zacks	Bull of the Day: Biogen Idec (BIIB) - Bull of the Day	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
27/08/2013	17:09	Business Wire	Rigrodsky & Long, P.A. Announces Investigation Of Onyx Pharmaceuticals, Inc. Buyout	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
27/08/2013	15:33	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
27/08/2013	10:15	Dow Jones News	Correction to Bayer, Onyx FDA Priority Review Story	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
27/08/2013	09:47	PR Newswire (US)	Ryan & Maniskas, LLP Announces Investigation of Onyx Pharmaceuticals, Inc.	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
27/08/2013	06:00	Dow Jones News	Bayer, Onxy Get FDA Priority Review for Sorafenib For Type of Cancer	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
27/08/2013	02:15	Dow Jones News	Bayer: FDA Priority Review for Nexavar Treatment of Thyroid Cancer	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
27/08/2013	01:30	PR Newswire (US)	Bayer and Onyx Pharmaceuticals Announce FDA Priority Review Designation of Nexavar® (sorafenib) Supplemental New Drug Applic...	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
26/08/2013	20:36	PR Newswire (US)	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Ony...	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)
26/08/2013	19:38	PR Newswire (US)	Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareh...	NASDAQ:ONXX	Onyx Pharmaceuticals, Inc. (MM)